Sun Pharmaceuticals Looks To Match Market Growth

Indian drugmaker Sun Pharmaceutical expects to record a profit in Bangladesh for the first time this financial year as the market evolves. Trends of increased marketing and more brand awareness will benefit the company, as well as projected 8.7% year-on-year (y-o-y) market growth. BMI expects the company to achieve its goal given the increasing opportunities available in Bangladesh's US$700mn pharmaceutical market.

To read the full article, please choose one of the following options: